BP-897
CAS No. 314776-92-6
BP-897( BP897 )
Catalog No. M14019 CAS No. 314776-92-6
BP-897 is the first, potent, selective partial dopamine D3 receptor agonist with Ki of 0.92 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 178 | Get Quote |
|
5MG | 282 | Get Quote |
|
10MG | 439 | Get Quote |
|
25MG | 707 | Get Quote |
|
50MG | 1008 | Get Quote |
|
100MG | 1332 | Get Quote |
|
500MG | 2655 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBP-897
-
NoteResearch use only, not for human use.
-
Brief DescriptionBP-897 is the first, potent, selective partial dopamine D3 receptor agonist with Ki of 0.92 nM.
-
DescriptionBP-897 is the first, potent, selective partial dopamine D3 receptor agonist with Ki of 0.92 nM; displays 70 times lower affinity for D2 (Ki=61 nM), low affinities for D1 and D4 (Ki= 3 and 0.3 uM) and α1 and α2 adrenergic receptor (Ki=60 and 83 nM), negligible affinities (Ki>1 uM) for muscarinic, histamine and opiate receptors; inhibits cocaine-seeking behaviour that depends upon the presentation of drug-associated cues, without having any intrinsic, primary rewarding effects.Parkinson Disease Phase 2 Discontinued.
-
In Vitro——
-
In VivoAnimal Model:Male Listar hooded rats Dosage:0.05, 0.5, 1 mg/kg Administration:i.p.; 30 min before the session Result:Reduced cocaine-seeking behaviour before the first infusion of cocaine, in a dose-dependent manner, at doses similar to those at which BP 897 produced its responses on rotations and c-fos expression.
-
SynonymsBP897
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor
-
Research AreaNeurological Disease
-
IndicationParkinson Disease
Chemical Information
-
CAS Number314776-92-6
-
Formula Weight417.553
-
Molecular FormulaC26H31N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (275.33 mM)
-
SMILESO=C(NCCCCN1CCN(C2=CC=CC=C2OC)CC1)C3=CC=C4C=CC=CC4=C3
-
Chemical NameN-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pilla M, et al. Nature. 1999 Jul 22;400(6742):371-5.
2. Wood MD, et al. Eur J Pharmacol. 2000 Oct 27;407(1-2):47-51.
3. Wicke K, et al. Eur J Pharmacol. 2001 Jul 20;424(2):85-90.
molnova catalog
related products
-
Trifluoperazine
Trifluoperazine is a Dopamine D2 receptor inhibitor(IC50 : 1.2 nM) and Treatment of schizophrenia.
-
Oxidopamine hydrochl...
Oxidopamine hydrochloride is an neurotransmitter dopamine antagonist.
-
ONC206
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??